Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease

Michal Kramer; Rita Ehrlich; Moshe Snir; Ronit Friling; Masha Mukamel; Dov Weinberger; Ruth Axer-Siegel

doi:10.1016/j.ajo.2004.04.064

Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease

Michal Kramer, Rita Ehrlich, Moshe Snir, Ronit Friling, Masha Mukamel, Dov Weinberger, Ruth Axer-Siegel

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Abstract

To report our experience with intravitreal triamcinolone acetonide (IVTA) injections for the treatment of sight-threatening vitritis. Interventional case series. Three patients with acute severe exacerbations of noninfectious panuveitis and vitritis were treated with IVTA injections alone or as an adjunct to systemic immunosuppressive agents. Rapid clearance of the vitreous inflammation with improvement in visual acuity was observed 1 to 2 weeks after injection. The effect lasted 2 to 6 months, with the shortest duration in the vitrectomized eye of Patient 1. Repeated injections were required in all patients. Intravitreal triamcinolone acetonide may be beneficial in selected cases of vitritis. This treatment modality has a rapid effect and may lower the use of systemic agents.

Original language	English
Pages (from-to)	666-667
Number of pages	2
Journal	American Journal of Ophthalmology
Volume	138
Issue number	4
DOIs	https://doi.org/10.1016/j.ajo.2004.04.064
State	Published - Oct 2004
Externally published	Yes

Access to Document

10.1016/j.ajo.2004.04.064

Cite this

@article{d2340631a5db4475aa01df3e3aff8261,

title = "Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease",

abstract = "To report our experience with intravitreal triamcinolone acetonide (IVTA) injections for the treatment of sight-threatening vitritis. Interventional case series. Three patients with acute severe exacerbations of noninfectious panuveitis and vitritis were treated with IVTA injections alone or as an adjunct to systemic immunosuppressive agents. Rapid clearance of the vitreous inflammation with improvement in visual acuity was observed 1 to 2 weeks after injection. The effect lasted 2 to 6 months, with the shortest duration in the vitrectomized eye of Patient 1. Repeated injections were required in all patients. Intravitreal triamcinolone acetonide may be beneficial in selected cases of vitritis. This treatment modality has a rapid effect and may lower the use of systemic agents.",

author = "Michal Kramer and Rita Ehrlich and Moshe Snir and Ronit Friling and Masha Mukamel and Dov Weinberger and Ruth Axer-Siegel",

year = "2004",

month = oct,

doi = "10.1016/j.ajo.2004.04.064",

language = "אנגלית",

volume = "138",

pages = "666--667",

journal = "American Journal of Ophthalmology",

issn = "0002-9394",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease

AU - Kramer, Michal

AU - Ehrlich, Rita

AU - Snir, Moshe

AU - Friling, Ronit

AU - Mukamel, Masha

AU - Weinberger, Dov

AU - Axer-Siegel, Ruth

PY - 2004/10

Y1 - 2004/10

N2 - To report our experience with intravitreal triamcinolone acetonide (IVTA) injections for the treatment of sight-threatening vitritis. Interventional case series. Three patients with acute severe exacerbations of noninfectious panuveitis and vitritis were treated with IVTA injections alone or as an adjunct to systemic immunosuppressive agents. Rapid clearance of the vitreous inflammation with improvement in visual acuity was observed 1 to 2 weeks after injection. The effect lasted 2 to 6 months, with the shortest duration in the vitrectomized eye of Patient 1. Repeated injections were required in all patients. Intravitreal triamcinolone acetonide may be beneficial in selected cases of vitritis. This treatment modality has a rapid effect and may lower the use of systemic agents.

AB - To report our experience with intravitreal triamcinolone acetonide (IVTA) injections for the treatment of sight-threatening vitritis. Interventional case series. Three patients with acute severe exacerbations of noninfectious panuveitis and vitritis were treated with IVTA injections alone or as an adjunct to systemic immunosuppressive agents. Rapid clearance of the vitreous inflammation with improvement in visual acuity was observed 1 to 2 weeks after injection. The effect lasted 2 to 6 months, with the shortest duration in the vitrectomized eye of Patient 1. Repeated injections were required in all patients. Intravitreal triamcinolone acetonide may be beneficial in selected cases of vitritis. This treatment modality has a rapid effect and may lower the use of systemic agents.

UR - http://www.scopus.com/inward/record.url?scp=7044269316&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2004.04.064

DO - 10.1016/j.ajo.2004.04.064

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:7044269316

SN - 0002-9394

VL - 138

SP - 666

EP - 667

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

IS - 4

ER -

Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease

Abstract

Access to Document

Other files and links

Fingerprint

Cite this